Below is an educational, technical answer to a question many patients and clinicians ask. These systems support diagnosis and follow-up by a clinician, who interprets the recordings and decides on any next steps. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Remote Cardiac Rhythm Monitoring for Arrhythmias
Remote cardiac monitoring uses wearable or connected devices to record a patient's heart rhythm outside the hospital, sending the data for review. Mobile cardiac telemetry (MCT), sometimes abbreviated MCOT, is a category of remote monitoring that can transmit rhythm data, often with the ability to flag events for review. It is used to help detect and characterize arrhythmias such as atrial fibrillation (AFib) and ventricular tachycardia that may occur intermittently and be missed by a brief in-clinic test.
How does AI-based arrhythmia analysis help?
Automated analysis can sift large volumes of recorded rhythm data and flag segments that may contain arrhythmias for closer review. This is intended to make the review workflow more efficient rather than to replace clinical judgment. RhythmTrack includes AI-enhanced arrhythmia classification and auto-report generation, per INVAMED. The clinician confirms the findings and makes any diagnostic or treatment decisions.
What This Means in Practice
RhythmTrack is intended for use within a clinician-directed monitoring pathway and per its documentation and local approvals. Descriptions of features and wear periods reflect INVAMED's product specifications rather than a diagnostic promise for any patient. AI-enhanced classification is intended to support clinician review, which remains the basis for interpretation and any decisions.
Key Considerations
- The monitoring duration and device type are chosen to match how frequently a patient's symptoms or events are expected, as determined by the clinician.
- Connectivity and secure cloud streaming underpin remote review, and data-handling practices should meet applicable requirements.
- Descriptions of features and wear periods reflect INVAMED's product specifications rather than a diagnostic promise for any patient.
Frequently Asked Questions
How is RhythmTrack worn?
Depending on the model, RhythmTrack is offered with discreet patch or belt wear, according to INVAMED.
How long can RhythmTrack be worn?
INVAMED describes RhythmTrack as supporting typical wear periods of 7 to 14 days or more, with the exact duration set by the ordering clinician.
How does RhythmTrack transmit data?
RhythmTrack uses cellular or Wi-Fi connectivity with secure cloud streaming, and includes AI-enhanced arrhythmia classification and auto-report generation, per INVAMED.
About INVAMED
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Clinical and Technical Context
RhythmTrack is INVAMED's mobile cardiac telemetry solution within this remote monitoring approach. Extended wear over days to weeks is intended to increase the chance of capturing infrequent arrhythmias compared with very short recordings. RhythmTrack combines patch or belt hardware with connectivity and a cloud platform for classification and reporting, per INVAMED. Wear format options such as patch or belt affect comfort during extended monitoring and are selected per the clinical need. RhythmTrack uses cellular or Wi-Fi connectivity with secure cloud streaming, per INVAMED's specifications. Connectivity and secure cloud streaming underpin remote review, and data-handling practices should meet applicable requirements. These systems support diagnosis and follow-up by a clinician, who interprets the recordings and decides on any next steps. Remote cardiac monitoring uses wearable or connected devices to record a patient's heart rhythm outside the hospital, sending the data for review. Whether AFib is present and what it means for a patient is determined by the interpreting clinician. Local registration, indication, and platform requirements should be confirmed for each market. It is used to help detect and characterize arrhythmias such as atrial fibrillation (AFib) and ventricular tachycardia that may occur intermittently and be missed by a brief in-clinic test. Final interpretation and any clinical decisions remain with the reviewing clinician.
Related on INVAMED
- Digital Health & Remote Monitoring — product category
- How long do you wear a heart monitor?
- AI-Enhanced Arrhythmia Classification Explained — A Technical Guide
- Understanding Extended Wear Periods
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.